SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Strengthening the reporting of Genetic Risk Prediction Studies: The GRIPS statement
14 references·0 citing·39 second hop
Strengthening the reporting of Genetic Risk Prediction Studies: The GRIPS statement (2011)Strengthening the reporting of Genetic Ri…The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA Statement for Repo…STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement (2009)STrengthening the REporting o…STREGA, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK… and CONSORT: for whom does the guideline toll? (2009)STREGA, STROBE, STARD, SQUIRE…A catalogue of reporting guidelines for health research (2009)A catalogue of reporting guid…The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies (2007)The Strengthening the Reporti…Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)Strengthening the Reporting o…Quality of Reporting of Cancer Prognostic Marker Studies: Association With Reported Prognostic Effect (2007)Quality of Reporting of Cance…Almost all articles on cancer prognostic markers report statistically significant results (2007)Almost all articles on cancer…Selective Reporting Biases in Cancer Prognostic Factor Studies (2005)Selective Reporting Biases in…Reporting Recommendations for Tumor Marker Prognostic Studies (2005)Reporting Recommendations for…Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) (2005)Reporting Recommendations for…Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative (2003)Towards Complete and Accurate…The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration (2003)The STARD statement for repor…The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)The Revised CONSORT Statement…Improving the Quality of Reporting of Randomized Controlled Trials (1996)Improving the quality of reporting of randomized controlled trials. The CONSORT statement (1996)The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials (2001)Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews (2005)Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement (2015)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network (2010)Why Science Is Not Necessarily Self-Correcting (2012)Viewing systematic reviews and meta-analysis in social research through different lenses (2014)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) (2015)Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement (2015)Reporting guidelines for health care simulation research: extensions to the CONSORT and STROBE statements (2016)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Meta-analysis of Observational Studies in Epidemiology A Proposal for Reporting (2000)Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement (2015)Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement (2015)Systematic Reviews: Identifying relevant studies for systematic reviews (1994)Empirical Evidence of Design-Related Bias in Studies of Diagnostic Tests (1999)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (Chinese edition) (2009)Guidance for Developers of Health Research Reporting Guidelines (2010)Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed (2011)Health Measurement Scales: A Practical Guide to Their Development and Use (1989)Empirical Evidence of Bias (1995)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration (2008)Reprint—Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Measuring inconsistency in meta-analyses (2003)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Strengthening the Reporting of Genetic Risk Prediction Studies: The GRIPS Statement (2011)Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting (2012)Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration (2012)Reducing waste from incomplete or unusable reports of biomedical research (2014)Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? (2020)Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis (2020)
this work references cited by second hop

References

  • 2009The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration28,094 cited
  • 2007The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies21,132 cited
  • 2001The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration3,828 cited
  • 2007Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration3,542 cited
  • 2003Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative3,215 cited
  • 2005Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)2,148 cited
  • 2003The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration1,214 cited
  • 2009A catalogue of reporting guidelines for health research1,047 cited
  • 2009STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement805 cited
  • 2005Reporting Recommendations for Tumor Marker Prognostic Studies780 cited
  • 2007Almost all articles on cancer prognostic markers report statistically significant results231 cited
  • 2005Selective Reporting Biases in Cancer Prognostic Factor Studies231 cited
  • 2009STREGA, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK… and CONSORT: for whom does the guideline toll?

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

116 cited
  • 2007Quality of Reporting of Cancer Prognostic Marker Studies: Association With Reported Prognostic Effect94 cited
  • Cited by

    No citing works inside the corpus for this window.